Skip to main content

Table 1 Demographic and clinical characteristics of patients in the Cancer Genome Atlas papillary thyroid cancer cohort and validated papillary thyroid cancer cohort

From: Ferroptosis-related gene signature predicts the prognosis of papillary thyroid carcinoma

Clinicopathological features TCGA(N = 507) Validated Cohort(N = 75)
Age (year)
Mean (SD) 47.26 (15.78) 44.09 (12.65)
  < 55岁 340 (67.06%) 57 (76.00%)
  ≥ 55岁 167 (32.94%) 18 (24.00%)
Gender, n (%)
 Male 136 (26.82%) 19 (25.33%)
 Female 371 (73.18%) 56 (74.67%)
Stage, n (%)
 Stage I 285 (56.21%) 61 (81.33%)
 Stage II 52 (10.26%) 8 (10.67%)
 Stage III 114 (22.49%) 4 (5.33%)
 Stage IV 55 (10.85%) 2 (2.67%)
Unknown 2 (0.39%) 0 (0.00%)
T status, n (%)
 T1 144 (28.40%) 46 (61.33%)
 T2 167 (32.94%) 5 (6.67%)
 T3 171 (33.73%) 14 (18.67%)
 T4 23 (4.54%) 10 (13.33%)
 TX 2 (0.39%) 0 (0.00%)
N status, n (%)
 N0 231 (45.56%) 25 (33.33%)
 N1 226 (44.58%) 50 (66.67%)
 NX 50 (9.86%) 0 (0.00%)
M status, n (%)
 MO 283 (55.82%) 73 (97.33%)
 M1 9 (1.78%) 2 (2.67%)
 MX 215 (42.41%) 0 (0.00%)